CLINICAL TRIALS PROFILE FOR OCUFLOX

All Clinical Trials for OCUFLOX

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT02373137 ↗	Descemet Endothelial Thickness Comparison Trial	Active, not recruiting	Stanford University	Phase 4	2015-01-22	The purpose of this study is to compare visual acuity outcomes of two types of endothelial keratoplasty: 1) Ultrathin Descemet's Stripping Endothelial Keratoplasty (DSAEK) or 2) Descemet's Membrane Endothelial Keratoplasty (DMEK). Half of the participants will be randomized to have DSAEK and the other half will have DMEK.
NCT02373137 ↗	Descemet Endothelial Thickness Comparison Trial	Active, not recruiting	University of California, San Francisco	Phase 4	2015-01-22	The purpose of this study is to compare visual acuity outcomes of two types of endothelial keratoplasty: 1) Ultrathin Descemet's Stripping Endothelial Keratoplasty (DSAEK) or 2) Descemet's Membrane Endothelial Keratoplasty (DMEK). Half of the participants will be randomized to have DSAEK and the other half will have DMEK.
NCT02373137 ↗	Descemet Endothelial Thickness Comparison Trial	Active, not recruiting	Oregon Health and Science University	Phase 4	2015-01-22	The purpose of this study is to compare visual acuity outcomes of two types of endothelial keratoplasty: 1) Ultrathin Descemet's Stripping Endothelial Keratoplasty (DSAEK) or 2) Descemet's Membrane Endothelial Keratoplasty (DMEK). Half of the participants will be randomized to have DSAEK and the other half will have DMEK.
NCT02373137 ↗	Descemet Endothelial Thickness Comparison Trial	Active, not recruiting	Winston Chamberlain, MD, PhD	Phase 4	2015-01-22	The purpose of this study is to compare visual acuity outcomes of two types of endothelial keratoplasty: 1) Ultrathin Descemet's Stripping Endothelial Keratoplasty (DSAEK) or 2) Descemet's Membrane Endothelial Keratoplasty (DMEK). Half of the participants will be randomized to have DSAEK and the other half will have DMEK.
NCT03933631 ↗	Pilocarpine Use After Kahook Goniotomy	Enrolling by invitation	Montefiore Medical Center	Phase 3	2019-05-01	The goal of this study is to determine whether using pilocarpine provides added benefit to the success of combined cataract + KDB surgery.
NCT04005079 ↗	Pilocarpine After Combined Cataract/Trabectome Surgery	Terminated	Montefiore Medical Center	Phase 3	2019-06-05	Combined cataract + trabectome surgery is a surgery designed to help lower the intraocular pressure (pressure in the eye) and hopefully reduce the need for topical drops, progression of glaucoma, and/or further glaucoma surgeries. The purpose of this study is to assess whether using pilocarpine, a medication which is FDA approved to induce miosis, (in other words cause the pupil to constrict or become smaller) provides additional benefit to the success of Trabectome and cataract surgery.

Clinical Trial Conditions for OCUFLOX

Condition Name

Condition Name for OCUFLOX
Intervention	Trials
Keratoplasty	1
Keratoplasty, Lamellar	1
Ocular Hypertension	1
Open Angle Glaucoma	1

Condition MeSH

Condition MeSH for OCUFLOX
Intervention	Trials
Glaucoma	2
Ocular Hypertension	1
Glaucoma, Open-Angle	1
Cataract	1

Clinical Trial Locations for OCUFLOX

Trials by Country

Trials by Country for OCUFLOX
Location	Trials
United States	4

Trials by US State

Trials by US State for OCUFLOX
Location	Trials
New York	2
Oregon	1
California	1

Clinical Trial Progress for OCUFLOX

Clinical Trial Phase

Clinical Trial Phase for OCUFLOX
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	2

Clinical Trial Status

Clinical Trial Status for OCUFLOX
Clinical Trial Phase	Trials
Active, not recruiting	1
Enrolling by invitation	1
Terminated	1

Clinical Trial Sponsors for OCUFLOX

Sponsor Name

Sponsor Name for OCUFLOX
Sponsor	Trials
Montefiore Medical Center	2
University of California, San Francisco	1
Oregon Health and Science University	1

Sponsor Type

Sponsor Type for OCUFLOX
Sponsor	Trials
Other	6